Literature DB >> 427779

Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker.

M J Siciliano, P E Barker, R Cailleau.   

Abstract

Seventeen recently established human breast carcinoma cell lines of metastatic origin (MDA series), HeLa cells, and MCF-7 (a well-established breast carcinoma cell line) were studied by starch gel electrophoresis for allozymic differences at 17 enzyme loci. Ten loci proved to be informative in establishing unique genetic signatures for all of the lines with the exception of MDA-134 and -309, which had the same genetic signatures. The probability of these latter two lines being of independent origin and finding their similar genetic signatures by chance is 0.07. These studies enable us to conclude that the chromosomal marker shown to be common to these breast carcinoma cell lines of metastatic origin is not present because of cross-contamination of the lines with other long-term lines or each other.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427779

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  Do you know the sex of your cells?

Authors:  Kalpit Shah; Charles E McCormack; Neil A Bradbury
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

2.  Ex-vivo analysis of the bone microenvironment in bone metastatic breast cancer.

Authors:  Karen M Bussard; Andrea M Mastro
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-12-02       Impact factor: 2.673

Review 3.  Cell cross-contamination in cell cultures: the silent and neglected danger.

Authors:  O Markovic; N Markovic
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-01       Impact factor: 2.416

4.  Cell culture quality control by rapid isoenzymatic characterization.

Authors:  D M Halton; W D Peterson; B Hukku
Journal:  In Vitro       Date:  1983-01

5.  Inhibition of hyperglycemia-induced angiogenesis and breast cancer tumor growth by systemic injection of microRNA-467 antagonist.

Authors:  Irene Krukovets; Matthew Legerski; Pavel Sul; Olga Stenina-Adognravi
Journal:  FASEB J       Date:  2015-05-27       Impact factor: 5.191

6.  Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.

Authors:  Elena A Kashentseva; Joanne T Douglas; Kurt R Zinn; David T Curiel; Igor P Dmitriev
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

7.  Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.

Authors:  Delisha A Stewart; Jason H Winnike; Susan L McRitchie; Robert F Clark; Wimal W Pathmasiri; Susan J Sumner
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

8.  Characterization of the DiFi rectal carcinoma cell line derived from a familial adenomatous polyposis patient.

Authors:  M Olive; S Untawale; R J Coffey; M J Siciliano; D M Wildrick; H Fritsche; S Pathak; L M Cherry; M Blick; P Lointier
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

9.  Two relative efficiencies of polymorphic enzymes for characterizing cell lines, detecting contaminations, and monitoring transplants.

Authors:  W C Wright
Journal:  In Vitro       Date:  1980-10

10.  Characterization of a cell line (SW756) derived from a human squamous carcinoma of the uterine cervix.

Authors:  R S Freedman; J M Bowen; A Leibovitz; S Pathak; M J Siciliano; H S Gallager; B C Giovanella
Journal:  In Vitro       Date:  1982-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.